Localisation of Neuregulin 1-β3 to different sub-nuclear structures alters gene expression

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• Neuregulins are growth factors that activate ErbB3 and ErbB4 receptors.
• Nuclear localization of neuregulins in various tumor types suggests novel intracellular functions.
• Understanding neuregulin's nuclear role is crucial for cancer biology.

Purpose of the Study:

• To investigate the sub-nuclear localization and function of Neuregulin 1 type I-β3 (NRG1-β3).
• To determine the mechanisms of NRG1-β3 nuclear import and retention.
• To elucidate NRG1-β3's role in receptor signaling and gene expression.

Main Methods:

• Immunohistochemistry to detect nuclear neuregulin expression in tumors.
• Utilized photoactivatable GFP-tagged NRG1-β3 to track its sub-nuclear re-localization.
• Employing site-directed mutagenesis to identify key residues for nuclear localization.
• Kinome array and transcriptomic analysis to assess downstream signaling and gene expression changes.

Main Results:

• NRG1-β3 localizes to nucleoli and spliceosomes within the nucleus.
• Nuclear retention of NRG1-β3 is independent of tyrosine kinase activity.
• Specific lysine mutations affect nucleolar and spliceosomal uptake, identifying key residues.
• NRG1-β3 activates HER4 and HER2 receptor signaling and induces Heat Shock Protein 70B' expression.

Conclusions:

• Neuregulin signaling can be activated within spliceosomes, independent of canonical cell surface receptor activation.
• Nuclear neuregulin functions suggest a novel mechanism for regulating gene expression in cancer.
• These findings open new avenues for targeting nuclear neuregulin pathways in oncology.